Trial ED Pack

Trial ED Pack consists of a three well-known medications (Viagra, Cialis and Levitra) designed for the treatment of erectile dysfunction.

Product dosage: 700mg
Package (num)	Per pill	Price	Buy
15	$4.00 Best per pill	$60.00 (0%)	🛒 Add to cart

Introducing the Trial Ed Pack, a carefully curated medical starter kit designed for individuals beginning treatment for erectile dysfunction. This pack includes a selection of proven phosphodiesterase type 5 (PDE5) inhibitors, allowing patients and clinicians to evaluate individual response, tolerability, and efficacy under professional guidance. Each medication is provided in low, standard dosages to facilitate safe initiation and personalized therapeutic adjustment. The Trial Ed Pack supports evidence-based practice by enabling a systematic approach to selecting the most suitable agent based on pharmacokinetics, side effect profile, and patient-specific factors.

Features

• Contains multiple PDE5 inhibitors (e.g., Sildenafil, Tadalafil, Vardenafil) in trial quantities
• Standardized low to moderate dosage forms (e.g., 25mg, 50mg, 10mg)
• Clearly labeled blister packs with individual medication identification
• Includes patient information leaflets for each medication
• Compact, discreet packaging compliant with medical standards
• Manufactured in FDA-approved facilities following GMP guidelines

Benefits

• Enables personalized treatment selection based on individual patient response and side effect profile
• Reduces initial treatment uncertainty by allowing comparison of onset, duration, and efficacy
• Supports clinician-guided therapeutic decision-making with real-world trial data
• Minimizes initial prescription waste and cost by providing smaller quantities for evaluation
• Improves patient adherence and satisfaction through involvement in treatment choice
• Provides a structured, safe introduction to erectile dysfunction pharmacotherapy

Common use

The Trial Ed Pack is intended for the initial management of erectile dysfunction in adult males. It is commonly prescribed for patients with no prior exposure to PDE5 inhibitors or those who have tried a single agent with suboptimal results. It is particularly useful in cases where comorbidities (e.g., diabetes, cardiovascular conditions) or concomitant medications may affect drug selection. The pack allows clinicians to determine the most appropriate medication based on individual patient needs, including desired duration of action, food interactions, and side effect tolerance.

Dosage and direction

Each medication within the Trial Ed Pack should be taken as directed by a healthcare provider, typically starting with the lowest available dose. Sildenafil and Vardenafil are generally taken approximately 30-60 minutes before sexual activity, while Tadalafil may be taken in advance or as a daily low-dose regimen depending on the formulation. Dosage should not exceed one tablet per 24-hour period for as-needed medications, or as prescribed for daily formulations. Tablets should be swallowed whole with water; crushing or splitting is not recommended unless specifically advised. Sexual stimulation is required for medication efficacy.

Precautions

Patients should undergo cardiovascular assessment before initiation, as sexual activity carries potential cardiac risk. Those with anatomical penile deformities (e.g., Peyronie’s disease) or conditions predisposing to priapism (e.g., sickle cell anemia) should use with extreme caution. PDE5 inhibitors may cause hypotension; patients taking antihypertensives should be monitored. Visual disturbances have been reported, particularly with Sildenafil and Vardenafil; patients with retinitis pigmentosa should avoid use. Alcohol consumption may increase incidence of side effects and should be limited. Medications should be stored securely to prevent accidental ingestion by children or others.

Contraindications

Concomitant use with nitrates (e.g., nitroglycerin, isosorbide mononitrate) or nitric oxide donors is absolutely contraindicated due to risk of severe hypotension. Patients with known hypersensitivity to any PDE5 inhibitor or excipients in the formulations should not use these medications. Severe hepatic impairment (Child-Pugh Class C) prohibits use of most PDE5 inhibitors. Unstable angina, recent myocardial infarction, stroke, or life-threatening arrhythmia within the last 6 months are contraindications. Concomitant use with potent CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) requires dosage adjustment or avoidance.

Possible side effects

Common side effects (≥1%) include headache, flushing, dyspepsia, nasal congestion, and dizziness. Visual disturbances (e.g., color tinge, blurred vision) occur more frequently with Sildenafil and Vardenafil. Back pain and myalgia are more associated with Tadalafil. Less frequently (<1%), patients may experience hypotension, syncope, prolonged erection (requiring medical attention if exceeding 4 hours), sudden hearing loss, or non-arteritic anterior ischemic optic neuropathy (NAION). Most side effects are dose-dependent and transient, typically resolving within hours. Persistent or severe adverse effects should prompt discontinuation and medical consultation.

Drug interaction

PDE5 inhibitors are primarily metabolized by CYP3A4; concomitant use with strong inhibitors (e.g., clarithromycin, itraconazole, protease inhibitors) may significantly increase plasma concentrations. Alpha-blockers (e.g., doxazosin, tamsulosin) may potentiate hypotensive effects—dosing separation or alternative treatment should be considered. Other antihypertensives may have additive blood pressure-lowering effects. Grapefruit juice may increase bioavailability of some PDE5 inhibitors and should be avoided. Concomitant use with other erectile dysfunction treatments is not recommended due to increased side effect risk.

Missed dose

For as-needed medications: If a dose is missed, take it when remembered if sufficient time remains before anticipated sexual activity. Do not double the dose or take more than one tablet within 24 hours. For daily Tadalafil: If a dose is missed, take it when remembered unless it is almost time for the next dose. Do not take two doses within 24 hours. Consistency in timing is less critical for daily dosing than with as-needed medications, but maintaining a regular schedule optimizes steady-state concentrations.

Overdose

Symptoms of overdose may include severe headache, profound hypotension, syncope, prolonged and painful erection, and visual disturbances. Management is supportive: maintain supine position with legs elevated to optimize cerebral perfusion. Intravenous fluids may be administered for hypotension. Priapism lasting more than 4 hours requires urgent urological intervention to prevent permanent tissue damage. Hemodialysis is not effective due to high protein binding. Symptomatic treatment should be provided under medical supervision. The maximum recommended dose should never be exceeded.

Storage

Store at room temperature (15-30°C/59-86°F) in the original packaging, protected from light and moisture. Keep blister strips intact until immediately before use. Do not store in bathrooms or other humid areas. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Proper storage ensures medication stability and efficacy throughout the treatment period.

Disclaimer

This Trial Ed Pack is available by prescription only and should be used under medical supervision. The information provided does not replace professional medical advice, diagnosis, or treatment. Always consult your healthcare provider for personalized recommendations. Individual response to medication may vary. Not for use by women, children, or individuals without erectile dysfunction. This product is not intended to prevent sexually transmitted infections or serve as contraception.

Reviews

“After struggling with ED for two years, my urologist recommended the Trial Ed Pack. Being able to compare different medications helped us identify that Tadalafil worked best for my lifestyle with minimal side effects. The structured approach took the guesswork out of treatment selection.” – James R., 58

“As a cardiologist, I appreciate how the Trial Ed Pack allows me to safely initiate ED treatment in my patients with cardiovascular concerns. The low starting doses and variety enable me to find the optimal balance between efficacy and safety profile.” – Dr. Elena Torres, MD

“The comparative approach saved me both time and money. I had previously tried Sildenafil with uncomfortable flushing, but through the trial pack discovered Vardenafil provided adequate results without significant side effects. The educational materials were particularly helpful.” – Michael T., 52

“My husband was hesitant to seek treatment until our physician explained the trial pack concept. Having multiple options reduced his anxiety, and the ability to start with low doses built his confidence. It truly facilitated an important conversation about our intimate health.” – Sarah L., 49